In particular semaglutide, a GLP-1RA approved for treating type 2 diabetes (T2DM) in 2017 and obesity in 2021, reduced drinking and relapse in alcohol-dependent rodents 7,8
Of the 32 semaglutide- treated patients that developed semaglutide ADAs, 19 patients (0.6% of the overall population) developed antibodies cross-reacting with native GLP-1
Triple-Hormone-Receptor Agonist Retatrutide for Obesity
The gap between the public relations campaign and the fax on my desk is manufactured by a combination of legislative handcuffs, government bureaucratic incompetence, and regulatory capture
If using an insulin syringe (29 to 31 gauge), you should feel minimal resistance
On-site solvent reprocessing: Some manufacturers are going beyond localized rinse reuse by installing on-site distillation or purification systems that enable full-scale, closed-loop solvent recycling